Skip to content

Mind Body Therapy for the Treatment of Chronic Pain

Mind Body Therapy for the Treatment of Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04039139
Enrollment
35
Registered
2019-07-31
Start date
2019-07-30
Completion date
2020-04-20
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Chronic Pain Syndrome

Brief summary

Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of Mind Body Syndrome Therapy (MBST) in reducing disability from back pain and alleviating back pain. The investigators will secondarily investigate whether MBST can improve participant quality of life and reduce the need for pain-related hospitalization. The design of the this study consists of 3 arms with one being the intervention (MBST), one being usual care, and one being a second mind-body intervention (active control). This education program consists of a series of personal interviews and group and/or individualized lectures/sessions. Participants will also be provided reading material to study during the intervention period, and asked to continue their usual care while going through the MBST program.

Interventions

BEHAVIORALMind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)

Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be partially blinded. Participants in the usual care arm will be blinded to the specifics of the interventions. Intervention participants will be blinded to the specifics of the intervention until after they have been randomized into that arm. Data analysis will be conducted by persons who are completely blinded.

Intervention model description

Usual Care, Intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient 18 \> years old * Chronic back pain * Pain persistent for ≥3 days/week for the past 3 months prior to enrollment * Willingness to consider mind-body intervention

Exclusion criteria

* Patients \< 18 years of age * Diagnosed organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome. Pain related to disc disease is not an exclusion unless there are neurological impairments. * Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia and bipolar disorder.

Design outcomes

Primary

MeasureTime frameDescription
Pain Disability: Roland Morris Disability Indexchange over 26 weeksChange in the Roland Morris Disability Index (Scale 0-24 with 24 being worst)

Secondary

MeasureTime frameDescription
Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey4 weeks, 8 weeks, 13 weeks, 26 weeksBack pain bothersomeness as determined from modified Brief Pain Inventory Survey. (Scale 0-10 with 10 being the worst)
Pain Bothersomeness: Brief Pain Inventory Survey4 weeks, 8 weeks, 13 weeks, 26 weeksWhole-body pain bothersomeness as determined from modified Brief Pain Inventory Survey (Scale of 0-10 with 10 being the worst)
Pain affecting enjoyment of life4 weeks, 8 weeks, 13 weeks, 26 weeksScale 0-10 with 10 being worst from Brief Pain Inventory
Average Pain: Brief Pain Inventory Survey4 weeks, 8 weeks, 13, weeks, 26 weeksAverage pain as determined in the Brief Pain Inventory Survey (Scale 0-10 with 10 being worst)
Pain-related hospital admissions26 weeksSelf reported. Number of pain-related hospital admissions, including emergency room visits
Complete resolution of pain disability: Roland Morris Disability4 weeks, 8 weeks, 13 weeks, 26 weekscomplete resolution of pain disability as measured by Roland Morris Disability (Scale 0-24 with 24 being worst)
Anxiety from pain: Pain Anxiety Symptom Scale-20 survey4 weeks, 8 weeks, 13 weeks, 26 weeksAnxiety from pain as determined from the Pain Anxiety Symptom Scale-20 survey (20 questions with scale of 0-5 with 5 being 'always' and 0 being 'never'

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026